Covid-19: Bahrain authorises emergency use of antiviral drug Paxlovid

Pfizer’s dental medicine is created to quit the infection triggering the infection from increasing in the body

The National Wellness Regulatory Authority (NHRA) today authorized the emergency situation use the dental Covid-19 antiviral, Paxlovid. The medicine has actually been authorized for people 18 years of ages and also over that experience light to modest signs and symptoms and also go to a raised threat of creating extreme Covid-19 that might cause death.

The choice complies with the analysis of information given by the maker Pfizer, executed by the NHRA’s Drug Products Law Division (PPR).

The NHRA kept in mind that The Ministry of Wellness has actually started importing treatments based on the pertinent requirements and also demands, with the medicine anticipated to get here in January.

Paxlovid includes 2, co-packaged antiviral medication (PF-07321332 and also Ritonavir) that are created to quit the infection triggering Covid-19 from increasing in the body and also consequently assist those contaminated to get rid of the viral infection.

Back to top button